+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies



Identification of microRNA biomarkers in type 2 diabetes: a meta-analysis of controlled profiling studies



Diabetologia 58(5): 900-911



The aim was to identify potential microRNA (miRNA) biomarkers of type 2 diabetes. Controlled studies were retrieved from PubMed to compare miRNA expression profiles of type 2 diabetes and nondiabetic control samples. Meta-analysis under a random effects model was conducted. Subgroup analyses examined tissue specificity and species specificity. Sensitivity analyses were also performed to explain the heterogeneity among studies. Results were represented as log odds ratios (logOR), 95% confidence intervals (CI) and p values after Bonferroni correction. Among 343 differentially expressed miRNAs in 38 miRNA expression profiling studies published between 1993 and March 2014, only 151 miRNAs were tested by multiple studies, out of which 102 miRNAs were reported to be upregulated or downregulated. Meta-analysis identified 51 significantly dysregulated miRNAs. The top upregulated miRNA was miR-142-3p (logOR 6.4721; 95% CI 4.9537, 7.9904; adjusted p = 4.60 × 10(-16)). The top downregulated miRNA was miR-126a (logOR 7.5237; 95% CI 4.7159, 10.3316; adjusted p = 3.01 × 10(-07)). The dysregulation of two miRNAs (miR-199a-3p and miR-223) was highly pancreas-specific and liver-specific. miR-30e was downregulated in patients with type 2 diabetes, while miR-92a was downregulated in animal models of diabetes. In sensitivity analysis, 40 out of 47 miRNAs (85%) were robustly and consistently dysregulated. This meta-analysis confirms that 40 miRNAs are significantly dysregulated in type 2 diabetes. miR-29a, miR-34a, miR-375, miR-103, miR-107, miR-132, miR-142-3p and miR-144 are potential circulating biomarkers of type 2 diabetes. In addition, miR-199a-3p and miR-223 are potential tissue biomarkers of type 2 diabetes.

(PDF emailed within 0-6 h: $19.90)

Accession: 058039991

Download citation: RISBibTeXText

PMID: 25677225

DOI: 10.1007/s00125-015-3510-2


Related references

Identification of candidate microRNA biomarkers in diabetic nephropathy: a meta-analysis of profiling studies. Journal of Nephrology, 2018

Identification of candidate microRNA biomarkers in renal fibrosis: a meta-analysis of profiling studies. Biomarkers 1-33, 2018

Identification of stress-related microRNA biomarkers in type 2 diabetes: a systematic review and meta-analysis. Journal of Diabetes, 2018

Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. Plos One 8(10): E77251-E77251, 2014

Omega-3 polyunsaturated fatty acids favourably modulate cardiometabolic biomarkers in type 2 diabetes: a meta-analysis and meta-regression of randomized controlled trials. Cardiovascular Diabetology 17(1): 98-98, 2018

Identification of Potential MicroRNA Biomarkers by Meta-analysis. Methods in Molecular Biology 1762: 473-484, 2018

Effect of Vitamin D Supplementation on Some Inflammatory Biomarkers in Type 2 Diabetes Mellitus Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Annals of Nutrition & Metabolism 73(1): 62-73, 2018

Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling. Gene 619: 10-20, 2017

Meta-immunological profiling of children with type 1 diabetes identifies new biomarkers to monitor disease progression. Diabetes 62(7): 2481-2491, 2013

Meta-analysis and meta-review of thyroid cancer gene expression profiling studies identifies important diagnostic biomarkers. Journal of Clinical Oncology 24(31): 5043-5051, 2006

Eating disorders in female patients with type 1 diabetes A meta-analysis of controlled studies. Diabetes 48(SUPPL 1): A324-A325, 1999

Meta-analysis of microRNA expression profiling studies in human cervical cancer. Medical Oncology 32(6): 510-510, 2016

MicroRNA expression profiling studies on bronchopulmonary dysplasia: a systematic review and meta-analysis. Genetics and Molecular Research 12(4): 5195-5206, 2015

Clinically relevant circulating microRNA profiling studies in pancreatic cancer using meta-analysis. Oncotarget 8(14): 22616-22624, 2017

Effects of ACEI/ARB in hypertensive patients with type 2 diabetes mellitus: a meta-analysis of randomized controlled studies. Bmc Cardiovascular Disorders 14(): 148-148, 2015